Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 9, Number 3, May 2009

Articles

Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
pp. 252-272(21)
Authors: Hegedus, Csilla; Ozvegy-Laczka, Csilla; Szakacs, Gergely; Sarkadi, Balazs

Favourites:
ADD

Multidrug Resistance Through the Spectacle of P-Glycoprotein
pp. 281-297(17)
Authors: Goda, Katalin; Bacso, Zsolt; Szabo, Gabor

Favourites:
ADD

Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
pp. 298-306(9)
Authors: Mayur, Y. c.; Peters, G. J.; Rajendra Prasad, V. V.S.; Lemos, C.; Sathish, N. K.

Favourites:
ADD

Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
pp. 307-319(13)
Authors: Wilson, T. R.; Johnston, P. G.; Longley, D. B.

Favourites:
ADD

Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
pp. 320-340(21)
Authors: Gimenez-Bonafe, Pepita; Tortosa, Avelina; Perez-Tomas, Ricardo

Favourites:
ADD
Favourites:
ADD

Fibrates in the Chemical Action of Daunorubicin
pp. 366-369(4)
Author: Balendiran, Ganesaratnam K.

Favourites:
ADD

Targeting Tumors Using Estrogen Receptor Ligand Conjugates
pp. 370-380(11)
Authors: Keely, N. O.; Meegan, M. J.

Favourites:
ADD

Hypoxia Helps Glioma to Fight Therapy
pp. 381-390(10)
Author: Amberger-Murphy, Verena

Favourites:
ADD

Mechanism of Drug Sensitivity and Resistance in Melanoma
pp. 391-397(7)
Author: La Porta, Caterina A.M.

Favourites:
ADD

HER-2 Signaling and Inhibition in Breast Cancer
pp. 419-438(20)
Authors: Browne, B. C.; O'Brien, N.; Duffy, M. J.; Crown, J.; O'Donovan, N.

Favourites:
ADD

The Applicability of mTOR Inhibition in Solid Tumors
pp. 439-450(12)
Authors: Konings, I.R. H.M.; Verweij, J.; Wiemer, E. A.C.; Sleijfer, S.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more